• Je něco špatně v tomto záznamu ?

LC-UV/MS methods for the analysis of prochelator-boronyl salicylaldehyde isonicotinoyl hydrazone (BSIH) and its active chelator salicylaldehyde isonicotinoyl hydrazone (SIH)

J. Bureš, H. Jansová, J. Stariat, T. Filipský, P. Mladěnka, T. Šimůnek, R. Kučera, J. Klimeš, Q. Wang, KJ. Franz, P. Kovaříková,

. 2015 ; 105 (-) : 55-63. [pub] 20141203

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16000437

Salicylaldehyde isonicotinoyl hydrazone (SIH) is an intracellular iron chelator with well documented potential to protect against oxidative injury both in vitro and in vivo. However, it suffers from short biological half-life caused by fast hydrolysis of the hydrazone bond. Recently, a concept of boronate prochelators has been introduced as a strategy that might overcome these limitations. This study presents two complementary analytical methods for detecting the prochelator-boronyl salicylaldehyde isonicotinoyl hydrazone-BSIH along with its active metal-binding chelator SIH in different solution matrices and concentration ranges. An LC-UV method for determination of BSIH and SIH in buffer and cell culture medium was validated over concentrations of 7-115 and 4-115 μM, respectively, and applied to BSIH activation experiments in vitro. An LC-MS assay was validated for quantification of BSIH and SIH in plasma over the concentration range of 0.06-23 and 0.24-23 μM, respectively, and applied to stability studies in plasma in vitro as well as analysis of plasma taken after i.v. administration of BSIH to rats. A Zorbax-RP bonus column and mobile phases containing either phosphate buffer with EDTA or ammonium formate and methanol/acetonitrile mixture provided suitable conditions for the LC-UV and LC-MS analysis, respectively. Samples were diluted or precipitated with methanol prior to analysis. These separative analytical techniques establish the first validated protocols to investigate BSIH activation by hydrogen peroxide in multiple matrices, directly compare the stabilities of the prochelator and its chelator in plasma, and provide the first basic pharmacokinetic data of this prochelator. Experiments reveal that BSIH is stable in all media tested and is partially converted to SIH by H2O2. The observed integrity of BSIH in plasma samples from the in vivo study suggests that the concept of prochelation might be a promising strategy for further development of aroylhydrazone cytoprotective agents.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16000437
003      
CZ-PrNML
005      
20160126103548.0
007      
ta
008      
160108s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jpba.2014.11.044 $2 doi
035    __
$a (PubMed)25527982
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Bureš, Jan $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
245    10
$a LC-UV/MS methods for the analysis of prochelator-boronyl salicylaldehyde isonicotinoyl hydrazone (BSIH) and its active chelator salicylaldehyde isonicotinoyl hydrazone (SIH) / $c J. Bureš, H. Jansová, J. Stariat, T. Filipský, P. Mladěnka, T. Šimůnek, R. Kučera, J. Klimeš, Q. Wang, KJ. Franz, P. Kovaříková,
520    9_
$a Salicylaldehyde isonicotinoyl hydrazone (SIH) is an intracellular iron chelator with well documented potential to protect against oxidative injury both in vitro and in vivo. However, it suffers from short biological half-life caused by fast hydrolysis of the hydrazone bond. Recently, a concept of boronate prochelators has been introduced as a strategy that might overcome these limitations. This study presents two complementary analytical methods for detecting the prochelator-boronyl salicylaldehyde isonicotinoyl hydrazone-BSIH along with its active metal-binding chelator SIH in different solution matrices and concentration ranges. An LC-UV method for determination of BSIH and SIH in buffer and cell culture medium was validated over concentrations of 7-115 and 4-115 μM, respectively, and applied to BSIH activation experiments in vitro. An LC-MS assay was validated for quantification of BSIH and SIH in plasma over the concentration range of 0.06-23 and 0.24-23 μM, respectively, and applied to stability studies in plasma in vitro as well as analysis of plasma taken after i.v. administration of BSIH to rats. A Zorbax-RP bonus column and mobile phases containing either phosphate buffer with EDTA or ammonium formate and methanol/acetonitrile mixture provided suitable conditions for the LC-UV and LC-MS analysis, respectively. Samples were diluted or precipitated with methanol prior to analysis. These separative analytical techniques establish the first validated protocols to investigate BSIH activation by hydrogen peroxide in multiple matrices, directly compare the stabilities of the prochelator and its chelator in plasma, and provide the first basic pharmacokinetic data of this prochelator. Experiments reveal that BSIH is stable in all media tested and is partially converted to SIH by H2O2. The observed integrity of BSIH in plasma samples from the in vivo study suggests that the concept of prochelation might be a promising strategy for further development of aroylhydrazone cytoprotective agents.
650    _2
$a aldehydy $x analýza $x krev $7 D000447
650    _2
$a zvířata $7 D000818
650    _2
$a kyseliny boronové $x analýza $x krev $7 D001897
650    _2
$a chelátory $x analýza $7 D002614
650    _2
$a chromatografie kapalinová $x metody $7 D002853
650    _2
$a kultivační média $x chemie $7 D003470
650    _2
$a stabilita léku $7 D004355
650    _2
$a hydrazony $x analýza $x krev $7 D006835
650    _2
$a kyseliny isonikotinové $x analýza $x krev $7 D007539
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a hmotnostní spektrometrie $x metody $7 D013058
650    _2
$a molekulární struktura $7 D015394
650    _2
$a potkani Wistar $7 D017208
650    _2
$a referenční standardy $7 D012015
650    _2
$a senzitivita a specificita $7 D012680
650    _2
$a spektrofotometrie ultrafialová $x metody $7 D013056
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Jansová, Hana $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
700    1_
$a Stariat, Ján $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
700    1_
$a Filipský, Tomáš $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
700    1_
$a Mladěnka, Přemysl $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
700    1_
$a Šimůnek, Tomáš $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
700    1_
$a Kučera, Radim $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
700    1_
$a Klimeš, Jiří $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic.
700    1_
$a Wang, Qin $u Duke University, Department of Chemistry, Durham, NC 22708, USA.
700    1_
$a Franz, Katherine J $u Duke University, Department of Chemistry, Durham, NC 22708, USA.
700    1_
$a Kovaříková, Petra $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. Electronic address: petra.kovarikova@faf.cuni.cz.
773    0_
$w MED00002894 $t Journal of pharmaceutical and biomedical analysis $x 1873-264X $g Roč. 105, č. - (2015), s. 55-63
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25527982 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160108 $b ABA008
991    __
$a 20160126103711 $b ABA008
999    __
$a ok $b bmc $g 1102718 $s 924643
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 105 $c - $d 55-63 $e 20141203 $i 1873-264X $m Journal of pharmaceutical and biomedical analysis $n J Pharm Biomed Anal $x MED00002894
LZP    __
$a Pubmed-20160108

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace